Keyphrases
Pharmacokinetics
62%
Japanese Patients
32%
Mizoribine
29%
Population Pharmacokinetics
28%
Carvedilol
28%
Caco-2 Cells
28%
Levofloxacin
24%
Peptide Transporter 1 (PepT1)
23%
Intestinal Epithelial Cells
23%
Kidney Epithelial Cells
23%
LS180 Cell
22%
Transcellular Transport
22%
LLC-PK1
21%
Metoprolol
20%
NONMEM
20%
Intestinal Absorption
20%
Epithelial Cell Line
18%
Apical Membrane
18%
Phenytoin
18%
Renal Disease
18%
Oral Clearance
17%
Bisoprolol
17%
Efflux
17%
Pharmacokinetic Variability
16%
Inhibitory Effect
16%
Organic Anion Transporter
15%
Brain Natriuretic Peptide
15%
Quinidine
15%
Basolateral Membrane
15%
Pharmacokinetic Parameters
15%
CYP2C
14%
PEPT2
14%
Transport System
14%
Atrial Natriuretic Peptide
14%
Ajmaline
13%
LLC-PK1 Cells
13%
Population Analysis
12%
Glycylsarcosine
12%
CYP2D6*10
12%
Hepatic Extraction
12%
Caco-2
12%
Japanese Workers
11%
Tacrolimus
11%
Diphenhydramine
11%
Cytochrome P450 2D6 (CYP2D6)
11%
CYP2C9
11%
Sampling Design
10%
Pharmacodynamics
10%
Renal Failure
10%
Cisplatin
10%
Intestine
10%
Tetraethylammonium
10%
Ureter
9%
Plasma Concentration
9%
Antiport
9%
Patients with Epilepsy
9%
Ligation
9%
Caco-2 Cell Monolayer
9%
Dosage Regimen
9%
Pharmacokinetic Analysis
9%
Human Intestinal Cells
9%
Intestinal Cell Line
9%
Metabolism
9%
Cisplatin-induced
8%
Rat Kidney
8%
Membrane Transport Mechanism
8%
Liver
8%
Methotrexate
8%
Metabolic Activity
7%
Glucuronidation
7%
Genetic Polymorphism
7%
Membrane Transport
7%
Functional Traits
7%
Genotype
7%
Simulation Study
7%
Renal Excretion
7%
Na +
7%
Procainamide
7%
Trough Concentration
7%
Old Japanese
7%
Carvedilol Enantiomers
7%
Tertiary Amine
7%
Cytochrome P450 3A4 (CYP3A4)
7%
CYP2C19
6%
Volume of Distribution
6%
Kidney
6%
Intestinal Metabolism
6%
Pediatric Patients
6%
PH Dependence
6%
Dose Effect
6%
Epithelial Transport
6%
Propranolol
6%
Hepatic Metabolism
6%
Pharmacokinetic Data
6%
Natriuretic Peptides
6%
Area under the Curve
6%
Oral Administration
6%
Arrhythmia
6%
OK Cells
6%
Rat Intestine
6%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Bioavailability
27%
Mizoribine
27%
Carvedilol
25%
Levofloxacin
24%
Transcellular Transport
21%
Transcytosis
21%
4 Aminohippuric Acid
21%
Metoprolol
20%
CYP2D6
20%
Carbon 14
18%
Glycylsarcosine
16%
Phenytoin
15%
Organic Anion Transporter
15%
Bisoprolol
15%
Effusion
14%
Pharmacokinetic Parameter
13%
Cytochrome P450 2C
13%
Ajmaline
13%
Kidney Failure
12%
Messenger RNA
12%
Quinidine
11%
Volume of Distribution
11%
Diphenhydramine
11%
Brain Natriuretic Peptide
10%
Cisplatin
10%
Tetrylammonium
10%
Elimination
10%
Pharmacodynamics
9%
CYP3A4
9%
CYP2C9
9%
Tacrolimus
8%
Atrial Natriuretic Factor
8%
Methotrexate
8%
CYP2C19
7%
Renal Excretion
7%
Kidney Disease
7%
Natriuretic Factor
6%
Sodium Ion
6%
Grepafloxacin
6%
Heart Arrhythmia
6%
Propranolol
6%
Congestive Heart Failure
6%
Acute Kidney Failure
6%
Nephrotoxicity
5%
Cilastatin
5%
Vancomycin
5%
Fosfomycin
5%
Imipenem
5%
Nateglinide
5%
Receptor
5%
Drug Concentration
5%
Probenecid
5%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
5%
Glibenclamide
5%
Cations
5%
Diuretic Agent
5%
Dipeptide
5%